Anoro Ellipta is a steroid-free inhaler that contains umeclidinium (a long-acting muscarinic antagonist, or LAMA) and vilanterol (a long-acting beta agonist, or LABA). It's FDA-approved for maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. This Ellipta inhaler is inhaled through the mouth once per day. Side effects aren't common, but some people have reported sore throat and diarrhea.
Anoro Ellipta (umeclidinium / vilanterol) is a combination of two medications that work together to help you breathe easier.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
How to use Anoro Ellipta (umeclidinium / vilanterol):
No, Anoro Ellipta (umeclidinium / vilanterol) doesn't contain a steroid. It's a combination of 2 different bronchodilators: a long-acting muscarinic antagonist (LAMA) and long-acting beta agonist (LABA). Inhaled corticosteroids help you breathe better by lowering inflammation in the airways, whereas LAMAs and LABAs relax the muscles in your airways. Your pulmonologist might prescribe an inhaled steroid for you to use in addition to Anoro Ellipta (umeclidinium / vilanterol) to help treat COPD. Of note, there is a triple combination inhaler that combines the same ingredients in Anoro Ellipta with a steroid called Trelegy Ellipta.
Yes. The two active ingredients in Anoro Ellipta are umeclidinium and vilanterol, which are 2 different types of bronchodilators. They work in different ways to open up the airways.
You might start to notice improvement in breathing within 30 minutes after taking a Anoro Ellipta (umeclidinium / vilanterol) dose. But because Anoro Ellipta (umeclidinium / vilanterol) is a maintenance inhaler for COPD, it can take several weeks to get the full effects of the medication. If you don't notice improvements to your breathing after using Anoro Ellipta (umeclidinium / vilanterol) every day, your pulmonologist might make changes to your COPD treatment. Don't use this as a rescue inhaler for sudden trouble breathing.
People who took Anoro Ellipta (umeclidinium / vilanterol) in clinical studies didn't report weight gain as a side effect. Contact your primary care provider if you experience unexplained weight gain. They can help identify what might be causing the weight gain and let you know if you need more medical attention.
Each new Anoro Ellipta (umeclidinium / vilanterol) inhaler has 30 doses, which lasts a month. Use the dose counter on the front face of the Anoro Ellipta (umeclidinium / vilanterol) inhaler to keep track of when you need to get a refill.
Anoro Ellipta (umeclidinium / vilanterol) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Don't use Anoro Ellipta (umeclidinium / vilanterol) if you're experiencing a COPD exacerbation because this medication won't provide immediate relief. Use a rescue inhaler, such as albuterol (Ventolin HFA), if you're having trouble breathing.
If you're using your rescue inhaler more often than usual, let your pulmonologist know because this could be a sign that your condition is getting worse. Don't use more doses of Anoro Ellipta (umeclidinium / vilanterol) than recommended because this won't improve your breathing. Rather, this can raise your risk for serious side effects, such as heart problems, tremors, and dizziness.
In addition, don't use Anoro Ellipta (umeclidinium / vilanterol) with other inhalers containing a LABA, such as salmeterol (Serevent Diskus) or formoterol (Perforomist). Doing so can also worsen side effects.
Inhaled medications, including Anoro Ellipta (umeclidinium / vilanterol), can sometimes cause a muscle spasm in your airways. This can lead to difficulty breathing, wheezing, cough, and chest discomfort. If you have a hard time breathing after inhaling Anoro Ellipta (umeclidinium / vilanterol), use your rescue inhaler and get medical attention right away.
Severe allergic reactions to Anoro Ellipta (umeclidinium / vilanterol) are possible, including life-threatening reactions like facial swelling, shock, and anaphylaxis (closing of the throat). Get medical attention right away if you notice hives, rash, red skin, swelling of the lips or tongue, or difficulty breathing after using Anoro Ellipta (umeclidinium / vilanterol).
Although rare, umeclidinium in Anoro Ellipta can raise the pressure in your eyes and worsen symptoms of glaucoma. Talk to your optometrist before using Anoro Ellipta (umeclidinium / vilanterol) if you have glaucoma because they might ask you to come in more often for eye exams. Also speak with them if you notice any changes to your vision while using the medication.
Anoro Ellipta should be used cautiously by people who have prostate problems or urinary retention. Umeclidinium in the inhaler can worsen these conditions and lead to difficulty urinating. Contact your prescriber if you notice difficulty urinating while using this medication.
Vilanterol in Anoro Ellipta can potentially raise your blood pressure and heart rate, as well as cause changes in heart rhythm. But these side effects are typically unlikely to happen if you're taking the recommended dose of Anoro Ellipta (umeclidinium / vilanterol). Your healthcare team might ask you to check your blood pressure and heart rate regularly at home if you have high blood pressure or other heart problems. Don't use Anoro Ellipta (umeclidinium / vilanterol) more often than recommended. Tell your care team if you have dizziness, fatigue, tremor, rapid heartbeat, or weakness after you use Anoro Ellipta (umeclidinium / vilanterol).
Vilanterol in Anoro Ellipta might cause potassium levels in your blood to drop too low. This is more likely to happen if you take too much Anoro Ellipta (umeclidinium / vilanterol). Symptoms of low potassium include tiredness, weakness, muscle cramps, and a racing heart. Don't take more Anoro Ellipta (umeclidinium / vilanterol) than prescribed. Seek medical help right away if Anoro Ellipta (umeclidinium / vilanterol) isn't helping your breathing get better.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 60 blisters of 62.5mcg/25mcg | 1 inhaler | $273.21 | $273.21 |
Each inhalation of Anoro Ellipta contains 62.5 mcg of umeclidinium and 25 mcg of vilanterol.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Anoro Ellipta (umeclidinium / vilanterol) will not be safe for you to take.